PSMD1 and COVID-19: In patients with prior SARS-CoV-2 infection, one round of vaccination substantially (3-4 fold) boosted S1-IgG titers independent of PCC status above the levels observed in unvaccinated post-COVID-19 individuals (Fig. 2d).